Similarly, it was estimated in a 1000-patient cohort that if all patients had CYP2C19 genotyping, to guide clopidogrel prescribing over a one-year period, 20 deaths due to cardiovascular disease would be averted—a 27% decrease, or one life saved for every 50 patients tested [26]. This evidence concerns the gene CYP2C19 and cardiovascular disorder.